Los Angeles, CA – According to filings with the U.S. Securities and Exchange Commission, Gallant Pet Inc. is raising $7 Million in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Aaron Hirschhorn played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Gallant Pet Inc.

The Gallant team is a collective of respected veterinarians, scientists, and some unbelievably dedicated entrepreneurs. Our work is the result of over 100 years of regenerative medicine experience, and a commitment to invest millions into the future of stem cell therapies. Whether it’s for proactive maintenance, or to treat age-related issues like osteoarthritis, banking your dog’s stem cells now could give them a powerful advantage throughout their lives.

To learn more about Gallant Pet Inc., visit http://gallant.com/

Contact:
Aaron Hirschhorn, Chief Executive Officer
855-442-5526
aaron@gallant.com
https://www.linkedin.com/in/aaronwh/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved